Novoprotein: Nanjing Jinli and Suzhou Jinling plan to reduce their holdings of company shares by no more than 0.5180% and 0.5203%, respectively

Novoprotein announced that shareholders Nanjing Jinli and Suzhou Jinling plan to reduce their holdings of the company's shares through centralized bidding, block trading, and inquiry transfer due to their own funding needs. Nanjing Jinli intends to reduce its holdings by no more than 363,500 shares, with a planned reduction ratio of no more than 0.5180%. Suzhou Jinling intends to reduce its holdings by no more than 365,100 shares, with a planned reduction ratio of no more than 0.5203%. The reduction period is within three months starting from three trading days after the announcement is disclosed